The Future of Flu Starts With You

You have the power to advance research that may change the future of seasonal influenza (flu) with 1 injection. Learn more about participating in the Ignite P303 Trial for an investigational vaccine aimed at preventing seasonal flu infection.

Seasonal flu vaccines during the 2021-2022 flu season were²:

A messenger RNA (mRNA) vaccine may offer broader protection by responding to changes in seasonal flu strains more quickly and creating stronger immune responses³.
The Ignite P303 Trial will look at the safety and immune response of an mRNA-based investigational vaccine aimed at preventing seasonal flu in adults aged 18 and older.

Who Can Join?
This clinical trial is looking for adult participants. To join, you must be:
⚪ 18 years of age or older
⚪ In good health
⚪ Not pregnant or planning on becoming pregnant for at least 3 months following your vaccine visit
Prior to enrolling in this trial, you should:
⚪ Not have received a seasonal flu vaccine in the past 5 months
⚪ Not have had a confirmed flu infection within 5 months

References:
1. Influenza (seasonal): ask the expert: influenza Q&A. World Health Organization. Published November 6, 2018. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
2. Price AM, Flannery B, Talbot HK, et al. Influenza vaccine effectiveness against influenza A(H3N2)-related illness in the United States during the 2021-2022influenza season. Clin Infect Dis. 2022;ciac941. doi:10.1093/cid/ciac941
3. Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG. New technologies for influenza vaccines. Microorganisms. 2020;8(11):1745.

Download Poster